The immunoreceptor tyrosine-based activation motif (ITAM) was discovered more than 15 years ago 1 . This conserved signalling motif, with a consensus sequence of YXXL-X 6-8 -YXXL/I (where X denotes any amino acid), is present in the cytoplasmic domain of transmembrane adaptor molecules that are preferentially expressed in haematopoietic cells. ITAM-containing adaptors associate with and mediate cell activation by immunoreceptors, including the T-cell receptor (TCR), the B-cell receptor (BCR) and Fc receptors (FcRs) that bind immunoglobulins 2 . The initial characterization of ITAM signalling and function, which was based predominantly on acute and high-avidity crosslinking of ITAM-coupled immunoreceptors, led to the paradigm that ITAMs mediate cell activation, and that activation is counterbalanced by a different set of receptors that contain inhibitory signalling motifs, termed immunoreceptor tyrosine-based inhibitory motifs (ITIMs) 3 . However, it was apparent from early studies that suboptimal engagement of TCRs and BCRs leads to the incomplete ITAM activation that is associated with anergy, a state in which cells are refractory to stimulation through the same receptors 4, 5 . So, low intensity and sustained activation of ITAM signals can desensitize ITAM-coupled immunoreceptors.
More recent work has revealed that ITAM-coupled receptors modulate signalling by other types of receptors, including Toll-like receptors (TLRs) and cytokine receptors, in myeloid cells, natural killer (NK) cells, T cells and plasmacytoid dendritic cells [6] [7] [8] [9] . The main ITAM-containing adaptors that are expressed by myeloid cells are FcRγ and DAP12. These adaptors associate with and mediate signalling by various receptors, including FcRs, integrins, TREMs (triggering receptors expressed on myeloid cells), immunoglobulin-like inhibitory receptors (such as leukocyte immunoglobulin-like receptors or myeloidassociated immunoglobulin-like receptors), paired immunoglobulin-like receptor A (PIRA), osteoclast associated receptor (OSCAR), CD200 receptors and CD300 molecules. The ligands for many of these receptors are not known, but they appear to be constitutively expressed by myeloid cells or by the cells with which myeloid cells interact. Thus, myeloid cells receive ongoing constitutive or 'tonic' signalling through ITAM-coupled receptors, and this has been proposed to be the mechanism by which these cells sense their environment and use this information to modulate responses to TLRs and cytokine receptors. As a result, this ensures that these responses are appropriate for the cell and tissue context 10 . Tonic signalling through ITAMcontaining adaptors suppresses responses downstream of TLR triggering but at the same time augments the activation of JAK (Janus kinase)-STAT (signal transducer and activator of transcription) signalling by interferon (IFN) receptors [6] [7] [8] [9] 11, 12 . ITAMcoupled receptors can also be activated strongly and rapidly by high-avidity ligands, such as immune complexes that crosslink FcRs. Such high-avidity activation has the opposite effect of tonic signalling -that is, it synergizes with TLR signals to activate pro-inflammatory gene expression while inhibiting cytokine-mediated signalling.
There is great interest in delineating the mechanisms by which ITAM signals cross-regulate heterologous receptors, such as TLRs and cytokine receptors, and in understanding the molecular basis for the switch in ITAM function that depends on the avidity of receptor ligation. There have been several recent advances in this area. First, low-avidity engagement of the high-affinity FcR for IgA (FcαR) was shown to result in the recruitment of the tyrosine phosphatase SHP1 (SRC-homology-2 (SH2)-domain-containing protein tyrosine phosphatase 1; also known as PTPN6) to the ITAM of FcαR-associated FcRγ. SHP1, in turn, inhibited signalling by other receptors, including FcγRs, the tumour-necrosis factor receptor (TNFR) and TLRs [13] [14] [15] . By contrast, high-avidity receptor ligation resulted in increased ITAM phosphorylation and a switch to the predominant recruitment of spleen tyrosine kinase (SYK), with concomitant induction of activating signals. Second, ITAM-coupled receptors and cytokine receptors were shown to be linked by calcium-mediated signalling pathways, and the ITAM-dependent activity 12 . In addition, the calcium-dependent phosphatase calcineurin was implicated in the inhibition of TLR signalling 16 . In this Opinion article, I summarize recent data that describe how calciumdependent signals that are downstream of ITAM-coupled receptors regulate cytokine and TLR signalling, and propose a model to explain the differential effects (activating or inhibitory) of ITAM signalling. I suggest that changing the avidity of receptor ligation alters the balance between calcium-mediated and other signalling pathways, and that this balance determines whether ITAM signalling elicits activating or inhibitory effects.
iTAMs and calcium signalling The ligation of ITAM-coupled receptors in myeloid cells leads to the phosphorylation of ITAM tyrosine residues by SRC family kinases, followed by the recruitment and activation of SYK (FIG. 1) . SYK then activates signalling molecules, such as Bruton's tyrosine kinase (BTK) and phosphoinositide 3-kinase (PI3K), and induces the phosphorylation of the scaffolding adaptor proteins B-cell linker (BLNK) and SLP76 (SH2-domain-containing leukocyte protein of 76 kDa) 2, 17 . These adaptors assemble into a multiprotein signalling complex that leads to the recruitment and activation of additional signalling molecules, including phospholipase Cγ (PLCγ). PLCγ hydrolyses phosphatidyl inositol 4,5-bisphosphate to generate the key second messengers diacylglycerol and inositol-1,4,5-trisphosphate (InsP 3 ).
Diacylglycerol activates protein kinase C (PKC), thereby leading to nuclear factor-κB (NF-κB) activation, and RAS guanyl-releasing protein (RASGRP), which contributes to the activation of mitogen-activated protein kinases (MAPKs) and, downstream, the activation of activator protein 1 (AP1) and ETS family transcription factors (FIG. 1) . InsP 3 leads to a calcium flux and the activation of calcineurin, which in turn leads to the activation of nuclear factor of activated T cells (NFAT).
InsP 3 also leads to the activation of CAMK and PYK2, which contribute to the activation of MAPKs and the transcription factors cyclic-AMP-responsive-element-binding protein (CREB) and myocyte-enhancer factor 2 (MEF2). SYK also activates MAPK cascades by a pathway that depends on the kinase tumour-progression locus 2.
So, three major downstream effector signalling pathways are activated by ITAM-coupled receptors: NF-κB, MAPKs (and downstream transcription factors) and calcium pathways (FIG. 1) . Of these effector signalling pathways, NF-κB and MAPKs are involved in cell activation and can also be activated by many other receptors, for example, receptors for microbial products, such as TLRs, and inflammatory cytokine receptors, such as the interleukin-1 receptor (IL-1R) and TNFR.
The activation of calcium pathways by ITAM-coupled receptors distinguishes them from macrophage-activating receptors, such as TLRs and inflammatory cytokine receptors 2, 17 . Acute activation of a transient calcium increase triggered by the highavidity ligation of ITAM-coupled receptors, together with activation of NF-κB and MAPK pathways, promotes cell activation 18 . For example, NFAT that has been strongly activated by a transient increase in calcium cooperates with NF-κB and AP1 to induce IL2 gene expression and drive lymphocyte activation; CAMKs contribute to the activation of NF-κB, MAPKs and CREB; and PYK2 can enhance MAPK activation 19, 20 . By contrast, chronic exposure to lowavidity ligands (such as soluble antigens or autocrine-acting ligands that are expressed by myeloid cells) results in increased basal intracellular calcium levels, with sustained oscillations in calcium concentrations that are observed at the single-cell level, which leads to different signalling and cellular responses. Tonic calcium signalling does not activate NF-κB or MAPKs, but is sufficient to activate NFAT, which, when activated in the absence of NF-κB or AP1, induces anergy in lymphocytes 18, 21, 22 . In addition, tonic calcium signalling is sufficient to increase the activity of CAMK, which has been proposed to serve a molecular memory function and transduce tonic calcium signals to regulate the basal activity of downstream signalling molecules 20, 22 (FIG. 1) . Tonic ITAM-mediated calcium signalling is observed in macrophages, as shown by the basal levels of tyrosine phosphorylation of ITAMs in FcRγ and DAP12, by the basal levels of , β 2 -integrin or TReM2 (triggering receptor expressed on myeloid cells 2)) leads to sRc-family kinase-dependent phosphorylation of tyrosines in the ITAM motif in the cytoplasmic domain of ITAM-containing adaptor molecules, followed by recruitment and activation of spleen tyrosine kinase (sYK). In myeloid cells, FcRγ and DAP12 are the major ITAM-containing adaptors and sYK is the major recruited kinase. sYK initiates a signalling cascade that leads to the activation of Bruton's tyrosine kinase (BTK), the formation of multiprotein signalling complexes which is coordinated by the scaffolding adaptors B-cell linker (BLNK) and sRc-homology-2-domaincontaining leukocyte protein of 76 kDa (sLP76) (which are partially redundant adaptors), and the activation of phospholipase cγ (PLcγ). PLcγ activates key downstream effector pathways through the generation of the second messengers diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (InsP 3 ) that activate the depicted kinase cascades, such as RAs guanyl-releasing protein (RAsGRP), mitogen-activated protein kinases (MAPKs), calmodulin-dependent kinase (cAMK) and protein tyrosine kinase 2 (PYK2), and downstream transcription factors, such as nuclear factor-κB (NF-κB), activator protein 1 (AP1), and eTs, cyclic AMP-responsive-elementbinding protein (cReB), myocyte enhancer factor 2 (MeF2) and nuclear factor of activated T cells (NFAT). PI3K, phosphoinositide 3-kinase; PKc, protein kinase c.
tyrosine phospho rylation of SYK 11, 23 , by the increased intracellular calcium concentration 16 and by the basal activity of CAMK and PYK2 (ReF. 12) . This is achieved by the constitutive internalization of ITAM-associated receptors as a result of their ongoing interactions with cognate ligands 24, 25 .
Cytokine and TLR signalling Tonic ITAM signalling inhibits TLRmediated responses. Experimental approaches that used low-avidity ligands to trigger low-intensity activation of ITAM-associated receptors or that deleted DAP12 and/or FcRγ have revealed that tonic ITAM signalling negatively regulates several different types of receptors, including TLRs, FcγRs, the TNFR and the scavenger receptor MARCO (macrophage receptor with collagenous structure) [13] [14] [15] [24] [25] [26] [27] . In addition, an important role for tonic signalling by TREM2 (which associates with DAP12) in the negative regulation of TLR signalling has also been reported 24, 25 , and a substantial body of work supports a role for SHP1 in mediating inhibition in some systems [13] [14] [15] . However, the molecular connections between ITAM-associated receptors and TLRs remain obscure. Several potential mechanisms of inhibition have been proposed, which have been reviewed recently [6] [7] [8] [9] and are summarized in BOX 1. A significant, more recent development is the demonstration that calcineurin negatively regulates TLR signalling pathways 16 . Jones and colleagues found that calcineurin is active in resting macrophages, an effect that is probably the result of the increased intracellular calcium concentration, and that it inhibits TLR-induced activation of NF-κB and MAPK pathways 16 . Calcineurin interacts with TLRs, MyD88 (myeloid differentiation primary-response gene 88) and TRIF (Toll/IL-1R (TIR)-domaincontaining adaptor protein inducing IFNβ), and thereby inhibits a proximal step in TLR signalling, probably by dephosphorylating signalling intermediates (FIG. 2) . It remains possible that activation of NFAT by calcineurin also contributes to the inhibition of TLR signalling; for example it might induce the expression of negative regulators of signal transduction 28 . The basal calcineurin activity that was observed in this study is probably maintained, at least in part, by tonic calcium signalling mediated by ITAM-coupled receptors, although this connection was not addressed experimentally in this instance.
Tonic ITAM signalling enhances IFNmediated responses. Our group has shown that tonic ITAM signalling by DAP12 or FcRγ and SYK enhances IFNα-and IFNγ-induced activation of JAKs and STAT1 (ReFs 11, 12) . This work showed that calciumdependent signalling pathways link ITAM-coupled adaptors and IFN receptors by a pathway consisting of DAP12 or FcRγ, SYK, calcium, CAMK and PYK2 (FIG. 2) . In mouse macrophages that were tightly adhered to tissue culture plates, integrins (which were recently identified to be coupled to DAP12 (ReFs 29-31)), were major contributors to tonic ITAM signalling, which indicates a role for macrophageextracellular matrix interactions in the positive regulation of IFN-mediated responses. The calcium-dependent tyrosine kinase PYK2 associates with SYK and JAKs and can relay signals between these two different receptor systems (FIG. 2) . SYK can also phosphorylate STAT1 directly 11 and thereby contributes to the preferential activation of STAT1 (relative to STAT3) in primed macrophages that express high levels of STAT1. Preferential activation of STAT1 in macrophages results in stronger pro-inflammatory responses to IFNα, and it is thought that ITAM-enhanced IFNAR (IFNα and β receptor) signalling might have a role in the pathogenesis of IFN-mediated diseases, such as systemic lupus erythematosus (SLE) 12 . The idea that ITAM-mediated signalling can regulate responses to IFNs is supported by a recent report that showed that STAT1 and IFNlike responses from human monocytes were activated in normal plasma following low-avidity ligation of FcγRs with monomeric IgG 32 . FcγR-mediated activation of STAT1 was apparent only when the inhibitory ITIM-containing FcγRIIb (low-affinity FcγR) receptor was blocked, which indicates that the FcγR-IFN-STAT1 connection is tightly regulated and silent when FcγRIIb is expressed at basal concentrations. The interactions between the FcγR-IFN-STAT1 pathways in human monocytes have been confirmed (I. Tassiulas and L.B.I., unpublished observations), and priming of monocytes with IFNγ has been shown to result in increased ITAM-mediated enhancement of IFNα-mediated signalling 11 . IFNγ priming can increase the positive effects of ITAMs on IFNα-mediated signalling by increasing STAT1 expression 11, 33 , by suppressing FcγRIIb expression 34, 35 and by inducing or inhibiting the expression of multiple ITAM-associated receptors (J. Chen and L.B.I., unpublished observations). So, communication between ITAM-coupled receptors and IFN-signalling pathways is bidirectional and allows for coupling and fine-tuning of responses to both sets of receptors.
Tonic ITAM signalling and osteoclastogenesis. A second example of a positive effect of tonic ITAM-and calcium-mediated signalling on the regulation of pathways that are downstream of other receptor types is co-stimulation of signalling that is mediated by the TNFR family member RANK (receptor activator of NF-κB; also • Recruitment and sequestration of molecules that are common to ITAM and TLR signalling pathways 7 • Recruitment of phosphatases by immunoreceptor tyrosine-based inhibitory motif (ITIM)-like sequences that are contained within immunoreceptor tyrosine-based activation motifs (ITAMs) 6 • Regulation of ITAM accessibility by association of adaptor cytoplasmic domains with plasma-membrane lipids, which promotes their partial activation and the inhibition of other receptors 9 • Induction of a basal activity of calcineurin by tonic calcium signalling, which interacts with and possibly dephosphorylates TLRs and other downstream signalling molecules 16 
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www.nature.com/reviews/immunol Nature Reviews | Immunology known as TNFRSF11A). RANK has a key role in osteoclastogenesis, which is the process of the differentiation of myeloid-lineage cells into multinucleated osteoclasts that resorb bone 36 . Integration of signalling by RANK and ITAMs is mediated, at least in part, by BTK and/or TEC (tyrosine kinase expressed in hepatocellular carcinoma), BLNK and SLP-76 (ReFs 17,37,38), and ITAM-dependent signalling is required for the calcium-dependent activation of NFATc1 that drives osteoclastogenesis; this work has been reviewed recently 36 .
A high-avidity switch ITAMs and TLR synergy. High-avidity ligation of ITAM-associated receptors strongly activates NF-κB and MAPK pathways and has been implicated in inflammatorycell activation 2 . For example, extensive crosslinking of activating FcRs by immune complexes cooperates with other activating stimuli to promote inflammation in settings such as a mouse model of arthritis and in nephritis that is associated with SLE 39 . Activating functions of DAP12 have also been described 8, 40 , and synergy between DAP12-associated TREM1 and TLRs drives pro-inflammatory cytokine production and enhances toxicity in mouse models of endotoxaemia and bacterial sepsis 41 . An atypical ITAM in the dectin-1 receptor (which is expressed by macrophages and dendritic cells) that recognizes yeast cell walls can synergize with TLR2 to induce pro-inflammatory cytokine production [42] [43] [44] . The mechanisms underlying this synergy include ITAM-mediated contributions to NF-κB and MAPK activation and the generation of an oxidative burst that synergizes with TLR signals (FIG. 3) . Signalling synergy can also induce the expression of feedback inhibitors, such as A20 or IL-10 (ReF. 45 and references therein); however, a discussion of this indirect regulation is beyond the scope of this Opinion article. Synergistic activation of direct TLR responses by high-avidity ligation of ITAM-coupled receptors is in contrast to the inhibition of TLR responses that occurs following low-avidity ligation; this contrast defines a switch in ITAM function that is associated with differential avidity of ligation of ITAM-coupled receptors.
Inhibition of cytokine signalling. In contrast to tonic ITAM signalling that is induced by low-avidity receptor ligation (which enhances cytokine signalling), high-intensity activation of ITAM-associated receptors inhibits cytokine-mediated JAK-STAT signalling. My group originally described the inhibition of IL-2 receptor (IL-2R) signalling in human T cells following high-avidity TCR crosslinking 46 . Inhibition was mediated by the activation of PKC and downstream extracellular-signal-regulated kinase (ERK; also known as MAPK1), and JAK activation was suppressed in the absence of changes in IL-2R expression (FIG. 3) . These results were confirmed and extended by william Paul's group, who showed that TCR-ligation mediated the inhibition of signalling that is induced by IL-2, IL-4, IL-6 and IFNα in mouse T cells 47 . Similar to our results with IL-2, inhibition of IL-4R signalling depended on PKC and ERK. Effective inhibition of IL-4R signalling required simultaneous activation of calcineurin (FIG. 3) and was mimicked by the addition of phorbol 12-myristate 13-acetate (PMA; to activate PKC) and ionomycin (to induce a calcium flux). Inhibition of cytokine-mediated signalling restrained T-cell proliferation and was proposed to regulate their differentiation into T helper 2 (T H 2) cells. Subsequently, we found that high-avidity ligation of FcγRs or dectin-1 inhibited IL-10R signalling in macrophages through a PI3K-and PKCβ-or PKCδ-dependent mechanism that induced the internalization of IL-10R 48, 49 . In addition, FcγR signalling inhibited IFNα-mediated signalling by a PKCβ-(and to a lesser extent PKCδ-) dependent mechanism that induced the recruitment of SHP2 to the IFNAR and increased SHP2 catalytic activity, but did not affect IFNAR cell-surface expression 50 . In all of these studies, inhibition of cytokine signalling was independent of new protein synthesis and therefore did not depend on the complementary inhibitory mechanism that is mediated by suppressor of cytokine signalling (SOCS) proteins 51 . The elements required for ITAMmediated inhibition of cytokine signalling (FIG. 3) are: first, the requirement for strong ITAM signalling that is induced by a highavidity ligand; and second, the dependence on PKC, which is activated downstream of PLCγ in parallel with the activation of , or endogenous TReM2 (triggering receptor expressed on myeloid cells 2 ) ligands, such as semaphorin 6D, are sufficient to induce tonic calcium signalling that leads to basal activity of calmodulin-dependent kinase (cAMK), protein tyrosine kinase 2 (PYK2) and calcineurin. PYK2 interacts with Janus kinases (JAKs) and enhances interferon (IFN)-induced JAK-sTAT (signal transducer and activator of transcription) signalling, whereas calcineurin interacts with Toll-like receptors (TLRs) and the adaptor molecule MyD88 (myeloid differentiation primary-response gene 88) and attenuates TLR signalling. calcineurin-mediated activation of nuclear factor of activated T cells (NFAT) and downstream target genes, which include phosphatases, e3 ubiquitin ligases and transcriptional repressors, may contribute to inhibition. sRc-homology-2-domain-containing protein tyrosine phosphatase 1 (sHP1) is recruited to partially and/or weakly phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) and can cross-inhibit TLRs. Low-avidity ligands do not substantially activate nuclear factor-κB (NF-κB) or mitogen-activated protein kinase (MAPK) pathways (not shown). IFNAR, IFNα and β receptor calcium signalling pathways (FIG.1) . PKC then inhibits cytokine signalling by activating ERK and SHP2 and inducing the internalization of cytokine receptors; however, the exact mechanisms by which PKC and downstream effectors inhibit cytokine signalling are yet to be determined. The calcium dependence of PKCβ and PKCδ isoforms, and the involvement of calcineurin in the inhibition of IL-4R signalling, suggest that the acute activation of calcium pathways could have a role in the inhibition of cytokine signalling. My laboratory and others have described another rapidly acting, direct, SOCSindependent pathway in which TLRs, IL-1R, TNFR and ITAM-coupled receptors can inhibit JAK-STAT signalling by cytokines that use the gp130 signalling subunit, such as IL-6 and oncostatin M [52] [53] [54] [55] [56] [57] . In this case, inhibition occurs through a p38-dependent mechanism that leads to increased association of SHP2 with gp130 and JAK1, and by receptor internalization (FIG. 3) . My group recently showed that this inhibitory mechanism also blocks signalling by IL-27R in human monocytes 58 , thereby identifying a mechanism by which this cytokine can switch from mediating pro-inflammatory activation of monocytes to regulatory functions in T cells during the course of an immune response. TLRs, IL-1R and TNFR inhibit gp130 signalling through p38 (FIG. 3) but only weakly activate calcium signalling and do not activate PKCβ or PKCδ, nor do they substantially inhibit signalling that is induced by IL-10 (J.D-Ji and L.B.I., unpublished observations) (FIG. 3) . So, the inhibition of signalling mediated by cytokines that do not utilize gp130, such as IL-10, requires the activation of ITAM-dependent signalling pathways.
The signal-switch hypothesis The insights into the mechanisms that regulate TLR and cytokine-mediated signalling that were obtained from the aforementioned studies lead us to propose a model that provides a possible molecular basis for the opposing effects of tonic versus acute and intense ITAM-mediated signalling. In resting macrophages that sample their environment through low-avidity basal ligation of ITAM-coupled receptors, PKC, MAPK and NF-κB activity is low, but intracellular calcium levels are sufficient to maintain a low-level activity of calcineurin (which inhibits TLR signalling), CAMK and PYK2 (which amplify IFNAR signalling) (FIG. 4a) . Following high-avidity receptor ligation, there is strong activation of NF-κB and an oxidative burst (which together augment TLR signalling), and activation of PKC and MAPKs (which inhibit cytokine JAK-STAT signalling) (FIG. 4b) . This signal-switch hypothesis clarifies how the same ITAMcoupled receptor can mediate directly opposing effects on signalling downstream of other receptors, and suggests that balance among ITAM-mediated signalling pathways plays an important part in regulating macrophage responses to a variety of stimuli.
Tonic ITAM signalling enables fine tuning of macrophage responses to their environment under physiological conditions. The switch to strong ITAM signalling that occurs in the setting of infection would augment signalling pathways downstream of pathogen recognition and promote host defence. At the same time, strong ITAM signalling would limit the autocrine action and potential toxicity of the cytokines that are produced during the inflammatory response. Therefore, differential effects of ITAM signalling on other signalling pathways, such as TLRs and cytokines, would promote a coordinated cellular response to infection and inflammation. 61 and dysregulated IL-10-mediated homeostatic responses in rheumatoid arthritis 49 . Therefore, modulation of ITAM signalling is an attractive new therapeutic approach for autoimmune and inflammatory diseases. This low-avidity signal is tranduced through spleen tyrosine kinase (sYK), phospholipase cγ (PLcγ) and inositol-1,4,5-triphosphate (InsP 3 ) to modulate calcium concentrations and therefore regulate the basal activity of calmodulin-dependent kinase (cAMK), protein tyrosine kinase 2 (PYK2) and calcineurin that modulate Toll-like receptor (TLR)-and cytokine-mediated responses to make them appropriate for the cell environment. b | Dramatic and acute changes in the environment (for example, formation of immune complexes that bind FcRs during infection) can lead to high-avidity ligation of ITAM-coupled receptors and strong activation of protein kinase c (PKc), mitogen-activated protein kinases (MAPKs) and nuclear factor-κB (NF-kB) by diacylglycerol (DAG) . The switch to a PKc-, MAPK-and NF-κB-dominant signal promotes synergy with TLRs and inhibits cytokine signalling. RAsGRP, RAs guanyl-releasing protein; RGD, arginine-glycyl-aspartic-acid motif.
Concluding remarks

